NSN 6505-01-714-9242 · NIIN 017149242 · FSC 6505
NO DASHES 6505017149242
In Stock
MOLNUPIRAVIR CAPSULES
Drugs and Biologicals
Technical characteristics
3 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | MOLNUPIRAVIR CAPSULES, 200MG, 40S |
| FEAT | SPECIAL FEATURES | INDICATED FOR THE TREATMENT COVID; MECHANISM OF ACTION: INHIBITS REPLICATION BY VIRAL MUTAGENESIS FOR THE TREATMENT OF MILD TO MODERATE CORONAVIRUS DISEASE WHO ARE AT A HIGH RISK FOR PROGRESSION TO SEVERE COVID; PACKAGED AS 200 MG CAPSULES; INTENDED FOR ORAL ADMINISTRATION; 40 CAPSULES PER BOTTLE; STORE AT 20C TO 25C(68F TO 77F); EXCURSIONS PERMITTED BETWEEN 15C TO 30C(59F TO 86F)(SEE USP CONTROLLED ROOM TEMPERATURE); FOR USE UNDER EMERGENCY USE AUTHORIZATION(EUA); SHELF LIFE: 24 MONTHS. |
| CTJS | UNPACKAGED UNIT WEIGHT | POUNDS MAXIMUM 0.1433 |